1
|
Hamid O, Sato T, Davar D, Callahan M, Thistlethwaite F, Aljumaily R, Johnson M, Arkenau HT, Ileana Dumbrava E, Izar B, Chen H, Marshall S, Yuan Y, Deo M, Stanhope S, Collins L, Mundy R, Abdullah S, Lopez J. 728O Results from phase I dose escalation of IMC-F106C, the first PRAME × CD3 ImmTAC bispecific protein in solid tumors. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
2
|
De Blasio M, Alexander N, Wong C, Wanrooy B, Deo M, Qin C, Tare M, Prakoso D, Ritchie R. The Relative Contribution of High Fat Diet and Hyperglycaemia and Their Combination to the Structural Phenotype of the Diabetic Heart. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
3
|
Velagic A, Li J, Qin C, Li M, Deo M, Marshall S, Woodman O, Horowitz J, Kemp-Harper B, Ritchie R. Nitroxyl Exerts Positive Inotropic and Vasodilator Effects in the Type 2 Diabetic Heart. Heart Lung Circ 2021. [DOI: 10.1016/j.hlc.2021.06.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
4
|
De Blasio M, Tate M, Prakoso D, Willis A, Deo M, Walsh J, Cohen C, Rofe A, Peng S, Qin C, Kiriazis H, Donner D, Watson A, Ritchie R. Defining the Characteristics of a More Clinically Relevant Mouse Model of Type-2 Diabetes (T2D)-Induced Cardiomyopathy. Heart Lung Circ 2019. [DOI: 10.1016/j.hlc.2019.06.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
5
|
Prakoso D, Kiriazis H, Tate M, Qian H, Deo M, Parry L, Gregorevic P, Du X, Chatham J, De Blasio M, Ritchie R. 5213Manipulation of cardiac O-GlcNAc modification alters cardiac function and remodelling in the setting of diabetic cardiomyopathy. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.5213] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- D Prakoso
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - H Kiriazis
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - M Tate
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - H Qian
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - M Deo
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - L Parry
- University of Melbourne, Melbourne, Australia
| | - P Gregorevic
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - X Du
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - J Chatham
- University of Alabama Birmingham, Birmingham, United States of America
| | - M De Blasio
- Baker Heart and Diabetes Institute, Melbourne, Australia
| | - R Ritchie
- Baker Heart and Diabetes Institute, Melbourne, Australia
| |
Collapse
|
6
|
Tate M, Willis AM, Deo M, De Blasio MJ, Prakoso D, Kiriazis H, Du XJ, Qian HW, McGee S, Gregorevic P, Ritchie RH. P2841Cardiac-selective targeting of histone deacetylase 4 to limit experimental diabetic cardiomyopathy. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p2841] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Tate
- Baker Heart and Diabetes Institute, Heart Failure Pharmacology, Melbourne, Australia
| | - A M Willis
- Baker Heart and Diabetes Institute, Heart Failure Pharmacology, Melbourne, Australia
| | - M Deo
- Baker Heart and Diabetes Institute, Heart Failure Pharmacology, Melbourne, Australia
| | - M J De Blasio
- Baker Heart and Diabetes Institute, Heart Failure Pharmacology, Melbourne, Australia
| | - D Prakoso
- Baker Heart and Diabetes Institute, Heart Failure Pharmacology, Melbourne, Australia
| | - H Kiriazis
- Baker Heart and Diabetes Institute, Experimental Cardiology Laboratory, Melbourne, Australia
| | - X.-J Du
- Baker Heart and Diabetes Institute, Experimental Cardiology Laboratory, Melbourne, Australia
| | - H.-W Qian
- Baker Heart and Diabetes Institute, Muscle Research and Therapeutics Laboratory, Melbourne, Australia
| | - S McGee
- Deakin University, School of Medicine, Melbourne, Australia
| | - P Gregorevic
- Baker Heart and Diabetes Institute, Muscle Research and Therapeutics Laboratory, Melbourne, Australia
| | - R H Ritchie
- Baker Heart and Diabetes Institute, Heart Failure Pharmacology, Melbourne, Australia
| |
Collapse
|
7
|
De Blasio M, Huynh N, Dubrana L, Prakoso D, Qin C, Tate M, Deo M, Oseghale O, Kiriazis H, Du X, Ritchie R. Progression of Markers Contributing to Cardiomyopathy in a Mouse Model of Type 1 Diabetes. Heart Lung Circ 2018. [DOI: 10.1016/j.hlc.2018.06.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
8
|
Prakoso D, De Blasio M, Kiriazis H, Qian H, Deo M, Jap E, Weeks K, Parry L, Du X, Gregorevic P, McMullen J, Ritchie R. Cardiac Remodelling and Inflammation Associated with Diabetic Cardiomyopathy is Mitigated by Phosphoinositide 3-Kinase P110α Gene Delivery. Heart Lung Circ 2017. [DOI: 10.1016/j.hlc.2017.06.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
9
|
Prakoso D, Kiriazis H, Tate M, Qian H, Deo M, Parry L, Gregorevic P, Du X, Chatham J, De Blasio M, Ritchie R. Using Gene Delivery to Target Cardiac O-GlcNAc Protein Modifications in the Diabetic Heart: Impact on Left Ventricular (LV) Function. Heart Lung Circ 2017. [DOI: 10.1016/j.hlc.2017.06.157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
10
|
Qin C, Rosli S, Kahlberg N, Jelinic M, Leo C, Deo M, Kiriazis H, Yang Y, Du X, Parry L, Ritchie R. Annexin-A1 Deficient Mice Exhibit Exaggerated Cardiovascular Dysfunction in Type 1 Diabetes. Heart Lung Circ 2017. [DOI: 10.1016/j.hlc.2017.06.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Prakoso D, De Blasio M, Kiriazis H, Qian H, Deo M, Jap E, Weeks K, Parry L, Du X, Gregorevic P, McMullen J, Ritchie R. Phosphoinositide 3-Kinase p110alpha Gene Therapy Rescues Diabetic Cardiomyopathy in a Type 2 Diabetic Model. Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
12
|
Shah K, Deo M. Modeling the Effects of Distinct Calcium Dynamics in Purkinje Cells in Delayed Afterdepolarization-Induced Triggered Activity. Heart Rhythm 2013. [DOI: 10.1016/j.hrthm.2013.09.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
13
|
Deo M, Wu E, McLay J, Jones P. Proteins Associated with the Cardiac Ryanodine Receptor Alter the Threshold for Store Overload-Induced Calcium Release. Heart Lung Circ 2012. [DOI: 10.1016/j.hlc.2012.08.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
14
|
Deo M, Pandit S, Vaidyanathan R, OConnell R, Milstein M, Musa H, Herron T, Anumonwo J, Jalife J, Berenfeld O. Role of Cytosolic Calcium Diffusion and Sarcolemmal T-Type Calcium Current in Triggered Activity in Purkinje Cells: A Simulation Study. Heart Rhythm 2011. [DOI: 10.1016/j.hrthm.2011.09.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/15/2022]
|
15
|
Abstract
The bidomain equations are widely used for the simulation of electrical activity in cardiac tissue. They are especially important for accurately modeling extracellular stimulation, as evidenced by their prediction of virtual electrode polarization before experimental verification. However, solution of the equations is computationally expensive due to the fine spatial and temporal discretization needed. This limits the size and duration of the problem which can be modeled. Regardless of the specific form into which they are cast, the computational bottleneck becomes the repeated solution of a large, linear system. The purpose of this review is to give an overview of the equations and the methods by which they have been solved. Of particular note are recent developments in multigrid methods, which have proven to be the most efficient.
Collapse
Affiliation(s)
- E J Vigmond
- Department of Electrical and Computer Engineering, University of Calgary, Calgary, Alta., Canada.
| | | | | | | | | |
Collapse
|
16
|
Arora NK, Ganguly S, Agadi SN, Irshad M, Kohli R, Deo M, Paul VK, Deorari AK, Chellani H, Prasad MS, Sharma D. Hepatitis B immunization in low birthweight infants: do they need an additional dose? Acta Paediatr 2003; 91:995-1001. [PMID: 12412879 DOI: 10.1080/080352502760272722] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 09/30/2022]
Abstract
AIM To determine the influence of gestation and weight on the development of protective anti-HB levels and geometric mean titres after three doses of HBV vaccine and to ascertain the need for a fourth dose in low birthweight infants. METHODS Hepatitis B vaccine (Enivac HB, Panacea Biotec Ltd., India) was given to 82 preterm (PT) and 60 term intrauterine growth-retarded (T-IUGR) infants at birth and at 6, 10 and 14wk of life. RESULTS Protective anti-HB levels (>10 mIU/ml) were reached in 86.6% (71/82) of PT infants and 96.7% (58/60) of T-IUGR infants after three doses of HBV vaccine (p = 0.044). The odds of having a protective response after the third dose of HBV vaccine was 1.25 (95% CI 1.02-1.53) with every one-week increase in gestation (p = 0.032). Birthweight was not associated with the development of a protective immune response. After the third dose, only 66.7% (8/12) of the PT infants whose mothers had anti-HB antibodies, developed protective anti-HB levels compared with 90% (63/70) of those with no maternal antibodies (p = 0.028). In PT infants after the fourth dose, there was a significant increase in the proportion of infants with protective antibody levels (8.6%, 95% CI 0.6-16.6%) among those with no maternal antibodies and 12.2% overall (95% CI 6.0-21.3) (p = 0.031 to 0.002) over that reached with the third dose. Administration of the fourth dose to T-IUGR infants did not confer such a benefit. CONCLUSION In HBV-endemic areas, PT infants, irrespective of their birthweights, may benefit from an additional dose of hepatitis B vaccine in a schedule starting at birth. This approach will prevent vertical transmission and bring their immune response up to par with term infants. Term intrauterine growth-retarded infants should be vaccinated as per the schedule recommended for normal term infants. However, studies in other settings with different vaccine formulations and a longer follow-up period will be required before this strategy can be practised more widely.
Collapse
Affiliation(s)
- N K Arora
- Department of Pediatrics, All India Institute of Medical Sciences, New Delhi.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Brewster R, Hardiman K, Deo M, Khan S, Bodmer R. The selector gene cut represses a neural cell fate that is specified independently of the Achaete-Scute-Complex and atonal. Mech Dev 2001; 105:57-68. [PMID: 11429282 DOI: 10.1016/s0925-4773(01)00375-6] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
The peripheral nervous system (PNS) of Drosophila offers a powerful system to precisely identify individual cells and dissect their genetic pathways of development. The mode of specification of a subset of larval PNS cells, the multiple dendritic (md) neurons (or type II neurons), is complex and still poorly understood. Within the dorsal thoracic and abdominal segments, two md neurons, dbd and dda1, apparently require the proneural gene amos but not atonal (ato) or Achaete-Scute-Complex (ASC) genes. ASC normally acts via the neural selector gene cut to specify appropriate sensory organ identities. Here, we show that dbd- and dda1-type differentiation is suppressed by cut in dorsal ASC-dependent md neurons. Thus, cut is not only required to promote an ASC-dependent mode of differentiation, but also represses an ASC- and ato-independent fate that leads to dbd and dda1 differentiation.
Collapse
Affiliation(s)
- R Brewster
- Department of Biology, The University of Michigan, 830 North University, 48109-1048, Ann Arbor, MI, USA
| | | | | | | | | |
Collapse
|